Bipolar disorder (BD) remains one of the most common psychiatric disorders with high morbidity and mortality. Several polymorphisms have been found to be implicated in the pathogenesis of BD, however, these loci have small effect sizes that fail to explain the high heritability of the disease. Here, we attempt to better understand the genetic basis of
bipolar disorder by identifying differentially expressed genes (DEG) in post-mortem brain tissues of patients with BD versus normal controls.
Methods
Nine publicly available gene expression data sets with 702 samples derived from human post-mortem brain tissues were used for differential expression analysis. 7 data sets were used for the discovery of the gene signature and the other two were left for independent validation. The multi-cohort analysis was performed using a random-effects model utilizing R and MetaIntegrator package.
Results
The analysis resulted in the identification of 13 up-regulated and 9 down-regulated genes in BD. The BD gene signature was further validated in two independent data sets and resulted in an Area Under the ROC Curve (AUC) of 0.74 and 0.73, respectively. Gene set enrichment analysis was performed and resulted in the identification of several biological processes and pathways related to BD including Ca transport, inflammation and DNA damage response.
Conclusion
Our findings support the previous findings that link BD pathogenesis to abnormalities in glial inflammation and calcium transport and also identify several other biological processes not previously reported to be associated with the development of BD. Such findings will improve our understanding of the genetic basis underlying BD and may have future clinical implications.
Keywords-Bipolar Disorder, differential expression, inflammation, calcium transport Background Bipolar disorder (BD) is a common psychiatric disorder characterized by alternating periods of depression and abnormally elevated mood associated with changes in the activity levels [1] . The lifetime prevalence of Bipolar disorder is approximately 2.4% with average age of onset of 25 years [2] .
BD is a highly heritable disease with overall heritability reaching up to 70% based on twin studies [3, 4] with the risk being 10-fold higher in the first degree relatives of those affected with BD when compared with normal population. The biological mechanisms underlying the etiology of bipolar disorder remain unclear with recent evidence pointing toward a significant role of disrupted Ca dynamics and oxidative DNA damage in the pathogenesis of BD [5, 6, 7] . Although several susceptibility loci with small effect sizes have been found to be associated with BD [8, 9] , there is no much evidence supporting the role of specific genes in the pathogenesis of the disease [10] .
In this study, we attempt to identify the specific genes and biological pathways associated with bipolar disorder. For this purpose, we analyze microarray gene expression data derived from post-mortem brain tissue to identify the deferentially expressed genes (DEG) between BD and normal cases. Detecting those genes and pathways would provide us with a better understanding of the molecular pathogenesis of this disease and may have a future therapeutic implications.
Data collection
We performed an extensive search of the Gene Expression Omnibus (GEO) database [11] looking for microarray gene expression data of bipolar disorder. A total of 9 data sets were identified (Table 1) with 702 human post-mortem brain samples. We used 7
data sets for discovery of the BD gene signature and kept 2 data sets out for independent validation of the gene signature performance.
The meta-analysis
We used R Programming language [12] and "Metaintegrator" package [13] which utilizes a gene expression meta-analysis workflow described by Haynes et al [14] . This approach computes a Hedges effect size [15] for each gene in each data set. These effect sizes are then pooled across all the data sets (see Additional file 1 and 2) using a random-effect model by assuming that results from each study is drawn from a single distribution and that each inter-study difference is just a random effect. The approach computes the log sum of p-values that each gene is up/down-regulated, then combine p-values using Fisher's method and finally performs Benjamini-Hochberg FDR correction across all genes [16] .
A gene would be deferentially expressed if the absolute value of its effect size is > 0, false discovery rate is <= 0.15 and it has to be significantly up/down regulated in all of the 7 training data sets with a heterogeneity P-value cutoff of 0.05 [17] . All discovery steps were conducted on the training data sets only.
Validation of the resulting gene signature
The performance of the resulting BD gene signature was further validated in the 2 independent cohorts with a total of 156 samples (Table 1 ). We used the Area Under the Receiver operating characteristic curve (AUC), Area Under the Precision Recall Curve (AUPRC) and accuracy as evaluation metrics.
Enrichment analysis
Functional Enrichment analysis was performed using Enrichr R package [18, 19] to identify the Gene Ontology (GO) biological processes and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enriched in the discovered genes.
Results
The meta-analysis process resulted in the identification of 13 up-regulated and 9 downregulated genes in the post-mortem brain samples of bipolar disorder cases compared with normal controls (Table 2 ).
Strong performance in the two validation data sets
We measured the discriminatory ability of our gene signature by applying it to the 2 independent data sets to assess its performance on unseen data (Figure 1 ).
In the first validation data set (GSE5388), the signature achieved an AUC of 0.74, AUPRC of 0.72, accuracy of 74% and sensitivity of 90%. In the second validation data set (GSE35977), the signature achieved an AUC of 0.73, AUPRC of 0.664, accuracy of 68.4% and sensitivity of 89%.
The signature performance in the validation data sets showed great consistency with the performance in the discovery data sets without overfitting (Summary AUC = 0.74, 95% CI = 0.67-0.80) ( Figure 2 ).
Enrichment analysis
Enrichment analysis has revealed that the discovered gene signature is incorporated in many significant KEGG pathways (Figure 3, Figure 4 ) and GO biological processes (Additional file 3, Additional file 4). Several of these biological processes were previously reported to be associated with bipolar disorder and other psychiatric disease, for example: inflammation, apoptosis, regulation of DNA damage response and Ca transport. We confirm this association and report other pathways and biological processes not previously reported to be associated with BD.
Discussion
Bipolar disorder is a highly heterogeneous disease and the genetic basis underlying its pathophysiology is complex [20] . Several genome-wide association studies (GWAS) have identified several copy number variants (CNVs) and single-nucleotide polymorphisms (SNPs) that seem to play a role in the high heritability of the disease but each of these variants has a small effect [21, 22] . Moreover, these studies failed to identify specific genes that may have a large effect in the pathogenesis of the disease, most likely due to small sample size.
Here we tried to overcome the problem of inadequate sample size by incorporating multiple microarray gene expression studies in a meta-analysis process to achieve high statistical power. Through this large scale gene expression analysis of 702 post-mortem brain samples, we managed to identify 13 up-regulated and 9 down-regulated genes in BD.
The resulting gene signature managed to achieve great performance in the two independent validation data sets. In the first validation cohort, the signature achieved an AUC of 0.74 and AUPRC of 0.72. In the second validation cohort, the signature achieved an AUC of 0.73 and AUPRC of 0.664.
The up-regulated genes were enriched in many biological processes [see Additional file 3] like Ca ion transport, cytoskeletal assembly, apoptotic signaling, intracellular signal transduction, cell migration, inflammation and response to DNA damage. Several of these biological processes have been reported to be associated with BD and other psychiatric disorders like Schizophrenia [23, 24, 25, 26] . These same processes are incorporated in the pathogenesis of atherosclerosis which may explain part of the association between BD and other cardiovascular diseases [27, 28, 29] . 
Conclusion
In this study, we provide more insights into the genetic basis of BD through the identification of differentially expressed genes in post-mortem brain tissues of BD patients compared with normal controls. Our discovered BD gene signature proved to be accurate and consistent as shown by its performance in the independent validation cohorts. The BD signature genes were enriched in a number of biological processes and pathways that were previously reported to have a role in the pathogenesis of BD, most importantly the pathways regulating Ca transport and inflammatory processes. Such findings, together with previous research will provide a more clear understanding of the molecular pathophysiology of BD and may have future therapeutic potentials by targeting these specific genes and pathways.
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